The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

672

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

January 31, 2026

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

Keverprazan

Potassium-competitive acid blocker

DRUG

Amoxicillin

Antibiotic for H. pylori eradication

DRUG

Furazolidone

Antibiotic for H. pylori eradication

DRUG

Colloidal Bismuth Pectin

Gastric mucosal protectant

All Listed Sponsors

lead

Nanjing First Hospital, Nanjing Medical University

OTHER